Home / Companies / BridgeBio Pharma, Inc. / 20 Jun 2025
BridgeBio Pharma, Inc.: meeting of 20 Jun 2025
Votes reported on Form N-PX, item by item
457 Form N-PX filers reported votes at the BridgeBio Pharma, Inc. meeting of 20 Jun 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
5 nominees; 77.1% of reported votes for; 92 filers withheld from or voted against at least one nominee.
1,506 vote records from 167 filers. 11 of the 167 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
634 vote records from 453 filers. 301 of the 434 filers that marked the item either way voted against management. 19 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
296 vote records from 166 filers. 2 of the 166 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
299 vote records from 168 filers. 70 of the 167 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
568 vote records from 167 filers. 20 of the 166 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | Against * | No report |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | Against * | For |
| Equitable | For | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | Abstain or withhold * | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | For | Against * | For |
| WisdomTree | For | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | For | Against * | For |
| Northern Trust and FlexShares | For | Against * | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | For | For | For |
| Voya | For | Against * | For |
| First Trust | For | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | Against * | For |
| Principal | Abstain or withhold * | Against * | For |
| Capital Group and American Funds | For | Against * | For |
| Pacific Life funds | For | For | For |
| Global X | For | Against * | For |
| Transamerica | For | Against * | For |
| AllianceBernstein | Abstain or withhold * | Against * | For |
| DWS | For | Against * | For |
| Allspring | For | Against * | For |
| MassMutual | For | Against * | For |
| Macquarie and Delaware Funds | For | Against * | For |
| Janus Henderson | For | For | For |
| Neuberger Berman | For | Against * | For |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Lord Abbett | For | For | For |
| Baird | No report | Against * | No report |
| Artisan Partners | For | Against * | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the BridgeBio Pharma, Inc. meeting?
457 Form N-PX filers reported votes at the meeting of 20 Jun 2025. On say-on-pay, 301 of 434 voted against management (69.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by BridgeBio Pharma, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for BridgeBio Pharma, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing BridgeBio Pharma, Inc. with a meeting date within three days of 20 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.